A detailed history of New York State Common Retirement Fund transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 122,398 shares of VKTX stock, worth $8.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122,398
Previous 59,063 107.23%
Holding current value
$8.43 Million
Previous $3.13 Million 147.49%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$49.84 - $70.47 $3.16 Million - $4.46 Million
63,335 Added 107.23%
122,398 $7.75 Million
Q2 2024

Jul 31, 2024

BUY
$47.39 - $80.2 $130,369 - $220,630
2,751 Added 4.89%
59,063 $3.13 Million
Q1 2024

May 07, 2024

BUY
$17.4 - $94.5 $295,643 - $1.61 Million
16,991 Added 43.21%
56,312 $4.62 Million
Q4 2023

Feb 01, 2024

BUY
$9.24 - $19.64 $5,627 - $11,960
609 Added 1.57%
39,321 $732,000
Q3 2023

Nov 07, 2023

SELL
$10.92 - $16.0 $25,399 - $37,216
-2,326 Reduced 5.67%
38,712 $429,000
Q2 2023

Aug 07, 2023

SELL
$14.84 - $24.79 $862,901 - $1.44 Million
-58,147 Reduced 58.62%
41,038 $665,000
Q1 2023

May 02, 2023

BUY
$8.08 - $17.33 $801,414 - $1.72 Million
99,185 New
99,185 $1.65 Million
Q2 2022

Aug 04, 2022

SELL
$2.11 - $3.15 $123,755 - $184,753
-58,652 Reduced 99.24%
452 $1,000
Q1 2022

May 05, 2022

BUY
$3.0 - $4.88 $68,484 - $111,400
22,828 Added 62.93%
59,104 $177,000
Q4 2021

Feb 02, 2022

SELL
$4.6 - $6.72 $1.15 Million - $1.69 Million
-250,897 Reduced 87.37%
36,276 $167,000
Q3 2021

Nov 02, 2021

SELL
$5.58 - $7.04 $83,527 - $105,381
-14,969 Reduced 4.95%
287,173 $1.8 Million
Q2 2021

Aug 02, 2021

BUY
$5.19 - $6.73 $2,828 - $3,667
545 Added 0.18%
302,142 $1.81 Million
Q4 2019

Feb 05, 2020

SELL
$6.38 - $8.73 $100,166 - $137,061
-15,700 Reduced 4.95%
301,597 $2.42 Million
Q3 2019

Nov 07, 2019

SELL
$6.55 - $8.6 $195,137 - $256,211
-29,792 Reduced 8.58%
317,297 $2.18 Million
Q2 2019

Aug 09, 2019

BUY
$7.67 - $10.63 $122,720 - $170,080
16,000 Added 4.83%
347,089 $2.88 Million
Q1 2019

May 08, 2019

SELL
$7.58 - $9.94 $40,083 - $52,562
-5,288 Reduced 1.57%
331,089 $3.29 Million
Q4 2018

Feb 08, 2019

BUY
$7.16 - $16.21 $1.75 Million - $3.95 Million
243,897 Added 263.73%
336,377 $2.57 Million
Q3 2018

Nov 07, 2018

BUY
$9.7 - $19.65 $190,653 - $386,220
19,655 Added 26.99%
92,480 $1.61 Million
Q2 2018

Aug 10, 2018

BUY
$3.88 - $12.74 $282,561 - $927,790
72,825 New
72,825 $691,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.